Abstract:Traumatic brain injury (TBI) is a prevalent disorder, but no effective therapies currently exist. An underlying patho-physiology of TBI includes the pathological elevation of autophagy. beta-Catenin, a downstream mediator of the canonical Wnt pathway, is a repressor of autophagy. The Wnt/beta-catenin pathway plays a crucial role in cell proliferation and neuronal plasticity/repair in the adult brain. We hypothesized that activation of this pathway could promote neuroprotection and neural regeneration following TBI. In the controlled cortical impact (CCI) model of TBI in C57BL/6 mice (total n = 160), we examined intranasal application of recombinant Wnt3a (2 mu g/kg) in a short-term (1 dose/day for 2 days) and long-term (1 dose/day for 7 days) regimen. Immunohistochemistry was performed at 1 to 14 days post-TBI to assess cell death and neurovascular regeneration. Western blotting measured canonical Wnt3a activity, expression of growth factors, and cell death markers. Longitudinal behavior assays evaluated functional recovery. In short-term experiments, Wnt3a treatment with a 60-min delay post-TBI suppressed TBI-induced autophagic activity in neurons (44.3 +/- 6.98 and 4.25 +/- 2.53 LC3+/NeuN+ double positive cells in TBI+Saline and TBI+Wnt3a mice, respectively; p < 0.0001, n = 5/group), reduced autophagic markers light chain 3 (LC3)-II and Beclin-1, as well as injury markers caspase-3 and matrix metalloproteinase 9 (MMP-9). The Wnt3a treatment reduced cell death and contusion volume (0.72 +/- 0.07mm(2) and 0.26 +/- 0.04mm(2) in TBI+Saline and TBI+Wnt3a mice, respectively; p < 0.001, n = 5/group). The 7-day Wnt3a treatment increased levels of beta-catenin and growth factors glial-derived growth factor (GDNF) and vascular endothelial growth factor (VEGF). This chronic Wnt3a therapy augmented neurogenesis (0.52 +/- 0.09 and 1.25 +/- 0.13 BrdU+/NeuN+ co-labeled cells in TBI+Saline mice and TBI+Wnt3a mice, respectively; p < 0.01, n = 6/group) and angiogenesis (0.26 +/- 0.07 and 0.74 +/- 0.13 BrdU+/GLUT1+ co-labeled cells in TBI+Saline and TBI+Wnt3a mice, respectively; p = 0.014, n = 6/group). The treatment improved performance in the rotarod test and adhesive removal test. Targeting the Wnt pathway implements a unique combination of protective and regenerative approaches after TBI.

Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes

Neuroprotective and regenerative roles of intranasal Wnt-3a Administration after focal ischemic stroke in mice.

Intranasal Wnt-3A Alleviates Neuronal Apoptosis in Early Brain Injury Post Subarachnoid Hemorrhage Via the Regulation of Wnt Target PPAN Mediated by the Moonlighting Role of Aldolase C

Intranasally Delivered Wnt3a Improves Functional Recovery After Traumatic Brain Injury By Modulating Autophagic, Apoptotic, And Regenerative Pathways In The Mouse Brain

MicroRNA-193a-5p Rescues Ischemic Cerebral Injury by Restoring N2-Like Neutrophil Subsets

Regulatory T Cell is Critical for Interleukin-33-mediated Neuroprotection Against Stroke.

Inhibition Of Histone Deacetylase 3 By Mir-494 Alleviates Neuronal Loss And Improves Neurological Recovery In Experimental Stroke

CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke

Wnt-3a improves functional recovery through autophagy activation via inhibiting the mTOR signaling pathway after spinal cord injury

Regulation of Microglial Activation by Wnt/β-Catenin Signaling After Global Cerebral Ischemia in Mice

Up-regulated expression of NT-3 attenuates cerebral ischemia/reperfusion injury in rats

Abstract WP301: STAT3 Inhibition Reduces Infarct and Neuroinflammation in Experimental Stroke

Minocycline Suppresses NLRP3 Inflammasome Activation in Experimental Ischemic Stroke

Nlrp3 Deficiency Ameliorates Neurovascular Damage In Experimental Ischemic Stroke

Abstract TP106: N-3 Polyunsaturated Fatty Acid Enhances Neurovascular Remodeling after Acute Cerebral Ischemia

Dl-3-n-Butylphthalide Reduced Neuroinflammation by Inhibiting Inflammasome in Microglia in Mice after Middle Cerebral Artery Occlusion

The protective effect of Wnt3a on inflammatory response in oxygen-glucose deprivation/reoxygenation (OGD/R) astrocyte model

CARD3 Promotes Cerebral Ischemia‐Reperfusion Injury Via Activation of TAK1

VEGFD/VEGFR3 signaling contributes to the dysfunction of the astrocyte IL-3/microglia IL-3Rα cross-talk and drives neuroinflammation in mouse ischemic stroke

Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota-Gut-Brain Axis

A New Compound W026B Alleviates Ischemic Brain Injury Through Inhibiting the Production of Inflammatory Cytokines in Pmcao and Tmcao, and Enhances the Beneficial Effect of Tpa